sions, particularly from specimens containing low titers of Chlamydia.
Chlamydial inclusions in smears or tissue from clinical specimens or in cell culture have conventionally been identified by Giemsa staining, immunofluorescence (IF) staining, or iodine staining methods. Iodine staining has been employed only for Chlamydia trachomatis biotypes because C. psittaci biotypes do not produce sufficient quantities of glycogen. Unfortunately, iodine-detectable glycogen may only be demonstrated during part of the chlamydial growth cycle (2). Earlier reports have shown that IF staining is more sensitive and specific than Giemsa staining for the direct detection of C. psittaci inclusions in clinical specimens and cell culture (12) . For the detection of C. trachomatis inclusions in conjunctival scrapings, IF staining has also been shown to be superior to Giemsa staining (7) . However, comparisons of the sensitivity of these two methods for the detection of C. trachomatis inclusions in cell culture have been inconclusive. Thomas et al. demonstrated enhanced sensitivity of IF staining in terms of inclusion counts, but this did not result in a greater rate of chlamydial isolation from clinical specimens (11) . In a similar comparison, Darougar et al. observed no marked differences in the number of C. trachomatis inclusions identified in cell cultures or in the rates of chlamydial isolation (3).
In this study, we utilized monoclonal antibodies which recognize a species-specific surface antigen of C. trachomatis (10) for IF staining of chlamydial inclusions in cell culture. IF staining was shown to be significantly more sensitive and rapid than Giemsa staining for the detection of C. trachomatis inclusions which were produced from clinical specimens inoculated into cell culture.
MATERIALS AND METHODS
Specimens. A laboratory strain of C. trachomatis F/ UW-6/Cx (1) or clinical specimens were used in this study. Specimens for isolation of C. trachomatis were collected from the urethra and cervix of women attending the Sexually Transmitted Disease Clinic at Harborview Medical Center, Seattle, Wash., or from pregnant women enrolled in a prospective study of chlamydial neonatal infection at the University Hospital, University of Washington, Seattle. Specimens were collected with calcium alginate urethrogenital swabs, placed in 1 ml of sucrose-phosphate-glutamate medium (8) , and frozen at -70°C until tested.
Inoculation of cell monolayers. Clinical specimens were inoculated onto DEAE-dextran-pretreated HeLa 229 cell monolayers as previously described (8), except that 0.5 ,ug of cycloheximide (Sigma Chemical Co., St. Louis, Mo.) per ml was added to the culture medium (9) . Each specimen was inoculated onto four separate HeLa cell monolayers and incubated for 48 or 72 h (passage 1). After incubation, two inoculated monolayers on 12-mm cover slips were fixed with methanol and stained with either Giemsa stain or fluorescent antibody. At 72 h the two remaining inoculated monolayers were passaged onto fresh monolayers and reincubated (passage 2). Specimens which demonstrated inclusions on passage 1 by both staining methods were not passaged a second time.
Monoclonal antibodies. Hybrid cell lines (C. trachomatis 2C1 and 1H8) which secrete monoclonal antibodies that recognize the species-specific major outer membrane protein of C. trachomatis were used to produce ascitic fluids in mice as previously described (10) . For the direct IF staining technique, immunoglobulins from ascitic fluid 2C1 were affinity purified on a protein A-sepharose column (Pharmacia Fine Chemicals, Uppsala, Sweden) (4). Fluorescein isothiocyanate-conjugated monoclonal antibodies (2C1) were prepared by the method described by Goding (6) . A 1:50 dilution of ascitic fluid (1H8) or fluorescein isothiocynate-conjugated monoclonal antibody (20 ,ug/ml) was used for the indirect and direct IF staining techniques, respectively.
Giemsa staining and IF staining. May-GrunwaldGiemsa staining (5) was performed as follows. A saturated solution of May-Grunwald stain (Hopking & Williams, Chadwell Heath, Essex, England) in methanol was applied to cover slips for 5 min, washed with water, and stained with 0.08% Giemsa stain (Fisher Scientific Co., Pittsburgh, Pa.) for 10 min. Cover slips were then washed with water, dehydrated sequentially with acetone, acetone-xylene (1:1), and xylene, and mounted with Permount (Fisher Scientific Co. recognize species-specific antigens provides a reproducibly sensitive and specific assay for detecting C. trachomatis inclusions in cell culture after only one passage. Furthermore, the time required to scan cover slips stained with fluorescent antibody (average time, 5 min) was less than half the time required to scan Giemsa-stained cover slips (average time, 12 min). These savings in time and material can substantially lower the cost of isolation and provide for earlier diagnoses.
